FDA Regulation of Weight-Loss Products

How does the FDA 510(k)/de novo clearance pathway differ from a drug NDA for weight‑loss treatments?

The treats medicines and weight‑loss devices as fundamentally different regulatory products: most pharmaceutical obesity treatments are reviewed and approved through the drug new drug application (NDA...